A pediatric case separated rapid benzodiazepine seizure suppression from sustained control and showed why focal findings between seizures did not settle the epilepsy classification.
The presentation was subtle and prolonged
Ohta and colleagues described a previously healthy girl whose episodes began at six years of age. She became less responsive, moved and spoke slowly, and made mistakes in daily activities for hours. These changes were initially not recognized as seizures.
At seven, an EEG during symptoms showed nearly continuous generalized spike-and-wave activity. Buccal midazolam terminated the electrical seizure and restored consciousness. Between episodes, however, the EEG also showed focal epileptic discharges, creating a potential source of diagnostic confusion.
Immediate control and maintenance control differed
The report described recurrence of absence status when continuous intravenous midazolam was discontinued, despite initial levetiracetam and clobazam treatment. After valproic acid was introduced, midazolam could be withdrawn successfully and the patient was discharged without recurrent seizures.
This sequence does not mean that midazolam had failed to suppress the acute episode. It distinguishes seizure suppression while a medicine is administered from a regimen that maintains control after the infusion ends. The presence of clobazam in the initial regimen also does not establish equivalence between its role and that of an intravenous midazolam infusion.
The EEG context affected diagnosis
The authors emphasized that focal interictal discharges could coexist with the generalized ictal pattern of absence status epilepsy. Reading a focal abnormality between events as definitive proof of focal epilepsy could therefore misclassify this presentation.
A benzodiazepine response was useful within the clinical and EEG chronology, but response alone did not define the complete syndrome. The prolonged, relatively mild alteration in behavior also made episode onset and termination difficult to identify without supporting observations.
What one case can establish
The paper documents an unusual diagnostic pattern and a treatment sequence in one child. It does not compare maintenance drugs in a trial, establish a success rate, or show that valproic acid will permit midazolam withdrawal in every similar patient. Its practical contribution is the separation of interictal findings, ictal findings, acute response, and later seizure control.
Source paper
Original analysis of the supplied journal article, identified as PMC12887091.
Leave a Reply